Tin Alley Ventures
VC Fund
Carlton, Australia
Tin Alley Ventures is a VC fund in Carlton focused on Biotechnology and Medical. Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Tin Alley Ventures invests in
Stages Tin Alley Ventures invests in
Countries Tin Alley Ventures invests in
Round sizes
Round size
- Pre-Seed
- $430k–$2.9M
Investment Focus
Industry
- Biotechnology 3 (43%)
- Medical 2 (29%)
- Software 2 (29%)
- Health Care 2 (29%)
- Life Science 2 (29%)
Stage
- Pre-Seed 5 (71%)
- Seed 1 (14%)
- Series B 1 (14%)
Country
- Australia 5 (71%)
- Philippines 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Kronus
|
Full-stack development infrastructure for safety-critical systems. | $429.8K / Pre-Seed / Jun 02, 2026 | |
Mirugen
|
Mirugen is a preclinical biotechnology company identifying the optimal set of cellular instructions to ask one cell type to become another. | $2.9M / Seed / Aug 13, 2025 | |
i14
|
We are i14 — we sit at the intersection of Computational Cognitive Science and AI research, and have developed a new class of models called Laplace Sequence Models that are an order of magnitude faster and more efficient and multiples more accurate than the transformer. We’ve also built a foundation model platform that allows organisations tocreate private, domain-specific expert models deployable across any environment (on-prem, at the edge, on device, in a private cloud, or hosted by i14). Our research lab continues to push beyond many of the limitations of current AI, and has a host of research projects which are continually integrated to update our foundation model platform. We recently closed a $4M initial round and are preparing for the next round. | $2.6M / Pre-Seed / May 23, 2025 | |
Cell Bauhaus
|
Cell Bauhaus uses mathematical and computer modeling to understand, predict, and modify living cell behavior, aiming to expedite sustainable solutions to humanity's pressing issues. | Pre-Seed / Oct 10, 2024 | |
Remagine Labs
|
Remagine Labs is revolutionizing healthcare with a bluetooth-connected, wearable electro-pharmaceutical that provide patient-centered care and consistent drug administration, giving healthcare customers peace of mind all over the world. | Pre-Seed / Oct 10, 2024 | |
Apromore
|
Apromore is a platform that offers process mining solutions to enhance operational efficiency and effectiveness. It enables business teams to visualize, analyze, and improve existing processes by leveraging data from various enterprise systems. The platform supports organizations in transforming their operations through actionable insights,ensuring better outcomes in customer experience and risk management. | $15M / Series B / Aug 06, 2024 | |
Psychae Therapeutics
|
Psychae Therapeutics develop innovative pharmaceutical grade DMT-based medicines and therapies aiming to transform the lives of those facing some of the most prolific and insidious mental illnesses | $2.9M / Pre-Seed / Nov 13, 2023 |
Co-Investors
Airtree Ventures
1 deal together
Brandon Capital
1 deal together
IP Group
1 deal together
La Ferla Ventures
1 deal together
NextGen Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Tin Alley Ventures invest in?
Tin Alley Ventures invests primarily in Biotechnology, Medical and Software startups, most often at Pre-Seed and Seed stage. Most of the 7 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Tin Alley Ventures's check size?
Tin Alley Ventures typically joins rounds of $430k–$2.9M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Tin Alley Ventures participates in.
When did Tin Alley Ventures last invest?
The most recent investment recorded for Tin Alley Ventures closed in Jun 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
